Filing Flows › Comparisons › SOLV vs DXCM
Solventum vs DexCom: SOLV and DXCM compared
Solventum is the larger company: $1.9B of revenue in its latest quarter (Q3 2026) against $1.3B for DexCom (Q3 2026). DexCom is growing faster (+11% against -7% a year earlier). DexCom is more profitable, with an operating margin of 24.3% against 3.5%.
Where the money goes: SOLV and DXCM
Solventum (SOLV) · Q3 2026
Solventum, Q3 2026: revenue $1.9B (-7% year over year), operating margin 3.5%, net loss $12.0M, operating cash flow $177M. The chart follows the revenue to costs, profit and cash.
DexCom (DXCM) · Q3 2026
DexCom, Q3 2026: revenue $1.3B (+11% year over year), operating margin 24.3%, net earnings $275M, operating cash flow $326M. The chart follows the revenue to costs, profit and cash.
| Solventum (SOLV) | DexCom (DXCM) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $1.9B | $1.3B |
| Revenue growth, Y/Y | -7% | +11% |
| Gross margin | — | 64.3% |
| Operating margin | 3.5% | 24.3% |
| Net earnings | −$12.0M | $275M |
| Net margin | -0.6% | 20.5% |
| Operating cash flow | $177M | $326M |
| Free cash flow | $97.0M | $273M |
| Market value | $15.6B | $30.6B |
| P/E | 99.4× | 31.5× |
| Analysts’ mean target | $96.92 | $98.15 |
Where the revenue comes from
Solventum
- Product: $1.4B (73%)
- Software and rentals: $518M (27%)
Questions
Which is bigger, Solventum or DexCom?
Solventum is the larger company: $1.9B of revenue in its latest quarter (Q3 2026) against $1.3B for DexCom (Q3 2026).
Is Solventum or DexCom growing faster?
DexCom is growing faster (+11% against -7% a year earlier).
Which is more profitable, Solventum or DexCom?
DexCom is more profitable, with an operating margin of 24.3% against 3.5%.
More: Solventum earnings · how Solventum makes money · DexCom earnings · how DexCom makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 5, 2026; 10-Q filed Oct 29, 2026). Fiscal quarters can end on different dates. Not investment advice.